|
1
|
Townsend M, Jeewa A, Khoury M, Cunningham
C, George K and Conway J: Unique aspects of hypertrophic
cardiomyopathy in children. Can J Cardiol. 40:907–920.
2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Braunwald E, Saberi S, Abraham TP, Elliott
PM and Olivotto I: Mavacamten: A first-in-class myosin inhibitor
for obstructive hypertrophic cardiomyopathy. Eur Heart J.
44:4622–4633. 2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Maron BJ, Desai MY, Nishimura RA, Spirito
P, Rakowski H, Towbin JA, Rowin EJ, Maron MS and Sherrid MV:
Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC
state-of-the-art review. J Am Coll Cardiol. 79:372–389.
2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lorenzini M, Norrish G, Field E, Ochoa JP,
Cicerchia M, Akhtar MM, Syrris P, Lopes LR, Kaski JP and Elliott
PM: Penetrance of hypertrophic cardiomyopathy in sarcomere protein
mutation carriers. J Am Coll Cardiol. 76:550–559. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Argiro A, Bui Q, Hong KN, Ammirati E,
Olivotto I and Adler E: Applications of gene therapy in
cardiomyopathies. JACC Heart Fail. 12:248–260. 2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bagnall RD, Singer ES, Wacker J, Nowak N,
Ingles J, King I, Macciocca I, Crowe J, Ronan A, Weintraub RG and
Semsarian C: Genetic basis of childhood cardiomyopathy. Circ Genom
Precis Med. 15(e003686)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Burns C, Bagnall RD, Lam L, Semsarian C
and Ingles J: Multiple gene variants in hypertrophic cardiomyopathy
in the era of next-generation sequencing. Circ Cardiovasc Genet.
10(e001666)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ommen SR, Mital S, Burke MA, Day SM,
Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, et
al: 2020 AHA/ACC guideline for the diagnosis and treatment of
patients with hypertrophic cardiomyopathy: Executive summary: A
report of the American college of cardiology/American heart
association joint committee on clinical practice guidelines.
Circulation. 142:e533–e557. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Maron MS, Masri A, Nassif ME,
Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Coats
CJ, Düngen HD, et al: Aficamten for symptomatic obstructive
hypertrophic cardiomyopathy. N Engl J Med. 390:1849–1861.
2024.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tuohy CV, Kaul S, Song HK, Nazer B and
Heitner SB: Hypertrophic cardiomyopathy: The future of treatment.
Eur J Heart Fail. 22:228–240. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhu C, Wang S, Ma Y, Wang S, Zhou Z, Song
Y, Yan J, Meng Y and Nie C: Childhood hypertrophic obstructive
cardiomyopathy and its relevant surgical outcome. Ann Thorac Surg.
110:207–213. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Price J, Clarke N, Turer A, Quintana E,
Mestres C, Huffman L, Peltz M, Wait M, Ring WS, Jessen M and Bajona
P: Hypertrophic obstructive cardiomyopathy: Review of surgical
treatment. Asian Cardiovasc Thorac Ann. 25:594–607. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Alsaied T, Khan MS, Rizwan R, Zafar F,
Castleberry CD, Bryant R III, Wilmot I, Chin C, Jefferies JL and
Morales DL: Pediatric heart transplantation long-term survival in
different age and diagnostic groups: Analysis of a national
database. World J Pediatr Congenit Heart Surg. 8:337–345.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tian A, Qiao S, Yuan J, Yang W, Yao Y, Jia
Y and Yang C: Comparison of percutaneous endocardial septal
radiofrequency ablation with alcohol septal ablation in treating
hypertrophic obstructive cardiomyopathy. Can J Cardiol.
41:1457–1465. 2025.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jiang T, Huang B, Huo S, Mageta LM, Guo J,
Lv J and Lin L: Endocardial radiofrequency ablation vs septal
myectomy in patients with hypertrophic obstructive cardiomyopathy:
A systematic review and meta-analysis. Front Surg.
9(859205)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu Q, Qiu H, Jiang R, Tang X, Guo W, Zhou
K, Chen Q, Sun Y, Yu L, Chen S, et al: Selective interventricular
septal radiofrequency ablation in patients with hypertrophic
obstructive cardiomyopathy: Who can benefit? Front Cardiovasc Med.
8(743044)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lawrenz T, Lawin D, Radke K and Stellbrink
C: Acute and chronic effects of endocardial radiofrequency ablation
of septal hypertrophy in HOCM. J Cardiovasc Electrophysiol.
32:2617–2624. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lu T, Zhu C, Nie C, Meng Y, Yang Q, Lu Z,
Song Y and Wang S: Understanding sex differences in hypertrophic
cardiomyopathy surgery: Insights from a decade-long cohort study
from China. J Am Heart Assoc. 14(e038421)2025.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhou M, Ta S, Hahn RT, Hsi DH, Leon MB, Hu
R, Zhang J, Zuo L, Li J, Wang J, et al: Percutaneous
intramyocardial septal radiofrequency ablation in patients with
drug-refractory hypertrophic obstructive cardiomyopathy. JAMA
Cardiol. 7:529–538. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Liu L, Li J, Zuo L, Zhang J, Zhou M, Xu B,
Hahn RT, Leon MB, Hsi DH, Ge J, et al: Percutaneous intramyocardial
septal radiofrequency ablation for hypertrophic obstructive
cardiomyopathy. J Am Coll Cardiol. 72:1898–1909. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xie X, Chen S, Cui Y, Zhou Z, Lu J, Du Z,
Ding J, Xing K, Zhang Y, Zhou Y, et al: Midterm outcomes of
percutaneous intramyocardial septal radiofrequency ablation for
hypertrophic cardiomyopathy: A single-center, observational study.
J Am Heart Assoc. 13(e034080)2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Altarabsheh SE, Dearani JA, Burkhart HM,
Schaff HV, Deo SV, Eidem BW, Ommen SR, Li Z and Ackerman MJ:
Outcome of septal myectomy for obstructive hypertrophic
cardiomyopathy in children and young adults. Ann Thorac Surg.
95:663–669. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sreeram N, Emmel M and de Giovanni JV:
Percutaneous radiofrequency septal reduction for hypertrophic
obstructive cardiomyopathy in children. J Am Coll Cardiol.
58:2501–2510. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xu H, Yan J, Wang Q, Li D, Guo H, Li S,
Wang J, Lou S and Zeng Q: Extended septal myectomy for hypertrophic
obstructive cardiomyopathy in children and adolescents. Pediatr
Cardiol. 37:1091–1097. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Laredo M, Khraiche D, Raisky O, Gaudin R,
Bajolle F, Maltret A, Chevret S, Bonnet D and Vouhé PR: Long-term
results of the modified Konno procedure in high-risk children with
obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg.
156:2285–2294.e2. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Fang J, Liu Y, Zhu Y, Li R, Wang R, Wang
DW, Song Y, Li C, Chen Y, Cheng L, et al: First-in-human
transapical beating-heart septal myectomy in patients with
hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol.
82:575–586. 2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen S, Chen L, Jiang Y, Xu H, Sun Y, Shi
H, Li S, Zhang J and Yan J: Early outcomes of septal myectomy for
obstructive hypertrophic cardiomyopathy in children with noonan
syndrome. Semin Thorac Cardiovasc Surg. 34:655–665. 2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Quintana E, Johnson JN, Sabate Rotes A,
Cetta F, Ommen SR, Schaff HV and Dearani JA: Surgery for
biventricular obstruction in hypertrophic cardiomyopathy in
children and young adults: Technique and outcomes†. Eur J
Cardiothorac Surg. 47:1006–1012. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American college
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
|
